Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02691507 · ClinicalTrials.gov registry record · Phase 2
Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema
A Phase 2 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT02691507 is a Phase 2 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 53 participants.
The verdict
NCT02691507, a Phase 2 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
The objective of this 1 week trial is to evaluate the efficacy of an over-the-counter (OTC) 1% colloidal oatmeal skin protectant cream in adults and children with mild to moderate AD.
Interventions
- DEVICE EpiCeram Skin Barrier Emulsion
- DRUG Experimental Product 1% Colloidal Oatmeal Balm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02691507
The ClinicalTrials.gov registry entry for NCT02691507 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EpiCeram Skin Barrier Emulsion is the first listed.
NCT02691507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02691507 about?
NCT02691507 is a clinical study titled "Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema". The objective of this 1 week trial is to evaluate the efficacy of an over-the-counter (OTC) 1% colloidal oatmeal skin protectant cream in adults and children with mild to moderate AD.
What is the current status of trial NCT02691507?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2016-02. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02691507?
The interventions under investigation include: EpiCeram Skin Barrier Emulsion (DEVICE), Experimental Product 1% Colloidal Oatmeal Balm (DRUG).
Who is sponsoring clinical trial NCT02691507?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.